The purpose of this study is to determine that a new drug called "Rivaroxaban®" is effective
in preventing patients from forming clots after their heart rhythm has been reset by the
cardiologist with an electrical device.
Drug: Warfarin and Enoxaparin
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01747746
Ages eligible for Study
18 Years and older
Genders eligible for Study
Accepts Healthy Volunteers
Patients with non-valvular atrial fibrillation requiring electrical cardioversion o Atrial fibrillation of unknown duration
Patients requiring extended anticoagulation after cardioversion due to concomitant risk factors as defined by CHADS2 score ≥ 1
Significant renal dysfunction (CrCl <15mL/min)
Significant hepatic dysfunction (Childs-Pugh Class B or C)
History of coagulopathy
Hypersensitivity to Rivaroxaban
Concomitant use of anticoagulants
Concomitant use of potent CYP3A4/P-gp inhibitors or inducers
Interventions requiring interruption of therapy
Age <18 y/o
History of GI Bleed
All locations for NCT01747746
United States (1)
Cook County Hospital
Chicago, Illinois, United States, 60612
View full eligibility
Tris trial is registered with FDA with number: NCT01747746. The sponsor of the trial is John H. Stroger Hospital and it is looking for 33 volunteers for the current phase.
Official trial title: Anticoagulation With Rivaroxaban in Post Cardioversion Patients
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Thank you for applying!
We'll contact you soon with more information.
Consult your doctor?
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.